🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

VSee Health partners with KALGOV for telehealth initiative

Published 10/16/2024, 09:14 PM
VSEE
-

BOCA RATON, Fla. - VSee Health, Inc. (NASDAQ:VSEE), a telehealth service provider, has teamed up with the Kwajalein Atoll Local Government and Kwajalein Atoll Sustainability Laboratory to launch a telehealth project designed to improve healthcare for Marshallese veterans and Kwajalein Atoll residents. The initiative, which utilizes Starlink satellite technology for virtual consultations on a boat ambulance, was successfully demonstrated on Friday, July 25, 2024.

The project aims to address the unique healthcare challenges faced by the remote atoll, where access to medical resources is limited. Kwajalein Atoll's main island, Ebeye, has the only hospital in the area, while many of the outer islands lack any trained healthcare personnel. This telehealth solution by VSee Health will enable residents to receive medical consultations from anywhere, enhancing the region's healthcare infrastructure.

During the demonstration, a Starlink satellite and VSee Telemedicine Kit allowed for real-time connections with healthcare professionals on land. The Kit, equipped with a laptop and digital medical devices, was tested by two American Coast Guard Academy cadets, who performed remote exams and consultations after a brief training session.

Mayor Hirata J. Kabua of Kwajalein Atoll expressed optimism about the project's positive impact on the community's healthcare system. KASL Executive Director Scott Paul highlighted the collaborative efforts that made the demonstration successful, and KASL Research Director Eric Rasmussen, MD, praised the telemedicine capability as life-saving technology.

VSee Health CEO Milton Chen emphasized the company's commitment to bridging the healthcare gap for veterans and residents. The introduction of this telehealth solution is expected to ensure no one is left without essential medical services.

VSee Health is a SaaS platform that enables the creation of telehealth workflows without programming, and is integrated with a range of telehealth technologies and a team of specialists for treating acutely ill patients.

This article is based on a press release statement.

In other recent news, VSee Health reported substantial growth following its merger and expansion of telehealth services. The company's Q2 2024 financial results showed a 33% increase in revenue to $1.7 million, mainly attributed to higher professional, technical, and engineering fees from customers. The first half of 2024 also saw an 11% increase in revenue to $3.2 million.

Meanwhile, VSee Health faced a Nasdaq compliance issue due to a delayed quarterly financial report filing. The company has been given until November 5, 2024, to present a plan to regain compliance, and it has expressed its intention to comply promptly.

In governance-related developments, the company expanded its Board of Directors by appointing Cydonii V. Fairfax and David L. Wickersham as new Class III directors, both meeting the independence criteria defined by Nasdaq rules.

VSee Health also made significant changes to its financial agreements, including amending the terms of its convertible promissory note with an institutional investor, extending the maturity date to June 30, 2026, and issuing an Equity Purchase Commitment Note of $500,000.

Lastly, the company launched a new telehealth program through its subsidiary iDoc Telehealth Solutions, aiming to deliver outpatient specialty medical services to inmates across several federal prisons. These are the recent developments in VSee Health's operations.

InvestingPro Insights

While VSee Health's innovative telehealth project in the Marshall Islands demonstrates the company's commitment to expanding healthcare access, recent financial data from InvestingPro paints a challenging picture for investors.

VSee Health's market capitalization stands at a modest $18.01 million, reflecting its status as a small-cap company in the telehealth sector. The company's revenue for the last twelve months as of Q2 2024 was $6.16 million, with a notable quarterly revenue growth of 32.66% in Q2 2024. This growth aligns with the company's efforts to expand its services, as evidenced by the Kwajalein Atoll project.

However, InvestingPro Tips reveal some concerning trends. The company is "quickly burning through cash" and "operates with a significant debt burden." These factors could impact VSee Health's ability to fund and sustain long-term projects like the one in the Marshall Islands. Additionally, the stock is "trading near its 52-week low" and has "fallen significantly over the last year," with a one-year price total return of -90.12%.

Investors considering VSee Health should note that the company is "not profitable over the last twelve months," with an adjusted operating income of -$0.42 million for the last twelve months as of Q2 2024. This financial situation underscores the importance of the company's strategic initiatives, such as the Kwajalein Atoll project, in potentially turning around its performance.

For a more comprehensive analysis, InvestingPro offers 11 additional tips on VSee Health, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.